Goldman Sachs initiates coverage on Solid Biosciences (NASDAQ: SLDB) with a Neutral rating and a price target of $31.00.Analyst Salveen ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE